Replies to post #118019 on Biotech Values

[jq1234]

Telaprevir and/or Boceprevir ought to be approved in China by the end of 2012

How can they be approved by the end of 2012 in China? They have not even filed SFDA application for registration trial over there yet.

China and Japan have their own drug application processes. FDA and EMA approval doesn't mean approval over there any time soon.

[oc631]

In short, I would say the big business opportunity for HCV drugs—Asia included—will come during the next 10 years, not in the decades thereafter.

Not only are you overstating the abilities of drug companies and Asian governments to reach patient populations but you are handicapping the virus.

[jq1234]

China faces uphill battle to give better healthcare

[The article quite accurately described China's current healthcare system for majority of people. Large number of poeple - because of the shear size of Chinese population - have much better heathcare than those described in the article.]

http://www.reuters.com/article/2011/04/08/us-healthcare-china-idUSTRE73721820110408